Robotic surgery aims to remove prostate through the perineum
NCT ID NCT04919057
First seen Sep 10, 2026 · Last updated Sep 11, 2026 · Updated 1 time
Summary
Researchers are testing a robotic approach to remove the prostate through the perineum, the area between the scrotum and anus, in men with localized prostate cancer. The study aims to see if the procedure can be completed safely and effectively using the GelPOINT device and a robotic system. Men aged 40 to 80 with early-stage prostate cancer that has not spread may be eligible. The trial will track complications, cancer recurrence, and changes in urinary and sexual function.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Robotic radical perineal prostatectomy using the GelPOINT device
- What this could lead to
- If it works, this could offer men with localized prostate cancer a less invasive way to remove the prostate, with better recovery of continence and erectile function.
- What could go wrong
- This is an early feasibility study with no participants enrolled, so it may not complete or show benefit. Robotic surgery carries risks of bleeding, infection, and urinary or sexual side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Expected to start
-
Jul 2025
An estimate. Start dates often move.
- Expected to finish
-
Mar 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
40 to 80 years
- Sex
-
Male participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Men aged between 40 - 80 years * Localized prostate cancer without obvious lymph node or distant metastases Exclusion Criteria: * Clinical T stage T3 or above * Prostate size \>80 ml * Patients with previous treatment of prostate cancer * Patients with previous surgery on the prostate * Patients with active urinary tract infection * Patients with bladder pathology including bladder stone and bladder cancer * Patients with urethral stricture * Patients with neurogenic bladder and/or sphincter abnormalities * Patients who fail to give informed consent
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Robotic radical perineal prostatectomy are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Prince of Wales Hospital, Chinese University of Hong Kong
Hong Kong, Hong Kong